Jubilant Life gets USFDA nod for normal anti-asthma tablets

Written By Unknown on Senin, 02 Maret 2015 | 23.25

As on December 31, 2014, the company had a total of 781 filings for formulations of which 333 have been approved in various regions globally.

Drug firm Jubilant Life Sciences  has received final approval from the US health regulator for generic Montelukast Sodium chewable tablets used in the treatment of asthma and to relieve symptoms of seasonal allergies.

"The company has received abbreviated new drug application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Montelukast Sodium chewable tablets..." Jubilant Life Sciences said in a statement. The approval is for the product in the strengths of 4 mg and 5 mg, it added.

"The total market size for Montelukast tablets as per IMS is USD 83 million per annum," Jubilant Life Sciences said. The tablets are generic version of Merck's Singulair chewable tablets used for the treatment of asthma and to relieve symptoms of seasonal allergies, it added.

As on December 31, 2014, the company had a total of 781 filings for formulations of which 333 have been approved in various regions globally," Jubilant Life Sciences said.

"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA approvals during FY2015," it added. Shares of Jubilant Life Sciences today closed at Rs 159.30 on BSE, down 0.22 percent from previous close. 

Jubilant Life stock price

On March 02, 2015, Jubilant Life Sciences closed at Rs 159.30, down Rs 0.35, or 0.22 percent. The 52-week high of the share was Rs 222.00 and the 52-week low was Rs 116.10.


The company's trailing 12-month (TTM) EPS was at Rs 27.17 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 5.86. The latest book value of the company is Rs 108.82 per share. At current value, the price-to-book value of the company is 1.46.


Anda sedang membaca artikel tentang

Jubilant Life gets USFDA nod for normal anti-asthma tablets

Dengan url

http://gayafashionshow.blogspot.com/2015/03/jubilant-life-gets-usfda-nod-for-normal.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Jubilant Life gets USFDA nod for normal anti-asthma tablets

namun jangan lupa untuk meletakkan link

Jubilant Life gets USFDA nod for normal anti-asthma tablets

sebagai sumbernya

0 komentar:

Posting Komentar

techieblogger.com Techie Blogger Techie Blogger